The miRoncol Real-time Multi-Cancer Early Risk Assessment is designed for healthy individuals and professionals who want meaningful insight into cancer risk as part of their preventive care strategy. It complements conventional screening programs and supports physician-led decision-making.
The miRoncol test helps fill this gap by analyzing molecular patterns linked to common solid tumours, giving you and your physician another layer of information for earlier conversations.
People already investing in nutrition, fitness, bio-tracking, or preventive health who want to add molecular-level insight to their health routines.
Those aware of hereditary cancer risk who want a real-time biological view beyond genetic predisposition and more than what public cancer screening programs can offer.
Individuals who know they carry a mutation (e.g. Lynch syndrome) and want to complement genetic testing with recurring molecular signals for regular monitoring due to their elevated life time risk..
Those who want to track how risk evolves with age and incorporate early risk assessment into longevity planning.
Clients of executive health clinics, integrative medicine programs, and wellness practitioners who want to add multi-cancer risk assessment to their proactive care.
The test is an early risk assessment tool not diagnostic. Results must always be reviewed with a physician and used to guide further evaluation where appropriate.
Whether you’re a proactive individual, a family with risk concerns, or part of an executive health program, miRoncol helps you take prevention further with clarity and confidence.